EXPECTED AUDIENCE SNAPSHOT

Attendance from

Biopharma (Mid-size & Emerging)

40%

Attendance from

Big Pharma

25%

Attendance from

CDMO / CMO

15%

Attendance from

Technology / Equipment / Solutions Providers

15%

Attendance from

Academia / Research / Government

5%

Decision Makers
By Geography

By Job Function

0%

External Manufacturing / Alliances

0%

Supply Chain / Procurement

0%

Quality / Tech Transfer Governance

0%

Operations Oversight

0%

Strategy / Business Development

0%

Digital / Data / Systems

Target Attendee Companies

Big Pharma

AbbVie
Amgen
Astellas
AstraZeneca
Bayer
Biogen
Boehringer Ingelheim
Bristol Myers Squibb
CSL Behring
Daiichi Sankyo
Gilead Sciences
GSK (GlaxoSmithKline)
Ipsen
Johnson & Johnson (Innovative Medicine)
Lundbeck
Merck Sharp & Dohme (MSD)
Moderna
Novartis
Novo Nordisk
Otsuka
Pfizer
Roche
Sanofi
Santen
Takeda

Biopharma

Immunocore
Autolus Therapeutics
Adaptimmune
Bicycle Therapeutics
Apollo Therapeutics
Relation Therapeutics
BenevolentAI
Exscientia
Amphista Therapeutics
AstronauTx
CellCentric
Clock.bio
Crescendo Biologics
Evox Therapeutics
Sitryx
Beacon Therapeutics
Mission Therapeutics
Mogrify
PhoreMost
Revolo Biotherapeutics
Cycle Pharmaceuticals
Dark Blue Therapeutics

ADC Manufacturers

AstraZeneca
GSK
Pfizer
Roche
MSD (Merck Sharp & Dohme)
Johnson & Johnson (Janssen / J&J Innovative Medicine)
Sanofi
AbbVie
Bristol Myers Squibb
Takeda
Eli Lilly
Iksuda Therapeutics
Pheon Therapeutics
Myricx Bio
Oxford BioTherapeutics
Antikor Biopharma
BiVictriX Therapeutics
Siftr Bio
Spirea
Get Your Ticket